Clinic
Southern Colorado Clinic PC
Southern Colorado Clinic PC was paid $17.42M by Medicaid between Jan 2018 and Dec 2024, across 133 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoSOUTHERN COLORADO CLINIC PC
PUEBLO, CO 81008
PUEBLO, CO 81008
33aNPI1285613554assigned 01/13/2006
33bProvider typeClinic/Center
28Total paid$17.42M
24GClaims365,338
24DCodes billed133
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Colorado
Rank by total paid#4 of 87
Median peer was paid$179K
This provider vs. median97×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 37,449 | $1.74M | |
| 2019 | 50,815 | $2.44M | |
| 2020 | 34,965 | $1.83M | |
| 2021 | 46,172 | $2.67M | |
| 2022 | 50,434 | $2.88M | |
| 2023 | 74,091 | $3.43M | |
| 2024incomplete | 71,412 | $2.43M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 108,220 | 99,808 | $6.16M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 61,005 | 55,391 | $4.51M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.8% | 17,738 | 16,794 | $1.54M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.7% | 4,914 | 4,644 | $640K |
| 87631 | 3.7% | 5,247 | 5,059 | $639K | |
| 64635 | 1.9% | 945 | 808 | $335K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.8% | 3,271 | 3,204 | $307K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 2,619 | 2,474 | $300K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.6% | 5,447 | 2,300 | $281K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.6% | 3,153 | 3,037 | $276K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.0% | 1,948 | 1,901 | $176K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.0% | 5,571 | 5,269 | $174K |
121 more codes
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,311 | $151K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 7,238 | $134K |
| 95886 | <1% | 1,734 | $130K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,478 | $113K |
| 64493 | <1% | 1,015 | $110K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,213 | $102K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 920 | $97K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,421 | $91K |
| 90836 | <1% | 2,286 | $91K | |
| 64636 | <1% | 1,133 | $77K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,892 | $73K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 701 | $70K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,094 | $61K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,092 | $58K |
| 64494 | <1% | 1,415 | $57K | |
| 96127 | <1% | 3,313 | $42K | |
| 95911 | <1% | 312 | $40K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,008 | $39K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 612 | $38K |
| 73564 | <1% | 1,961 | $36K | |
| 72100 | <1% | 1,439 | $32K | |
| 96112 | <1% | 274 | $30K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 320 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,932 | $24K |
| 64490 | <1% | 281 | $24K | |
| 20610 | <1% | 876 | $23K | |
| 73610 | <1% | 1,303 | $21K | |
| 73630 | <1% | 1,516 | $20K | |
| 99152 | <1% | 1,215 | $20K | |
| 27096 | <1% | 184 | $18K | |
| 81002 | <1% | 5,574 | $16K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 607 | $15K |
| 90688 | <1% | 3,429 | $12K | |
| 94760 | <1% | 6,569 | $12K | |
| 90670 | <1% | 2,468 | $11K | |
| 95885 | <1% | 242 | $11K | |
| 73030 | <1% | 666 | $11K | |
| 64491 | <1% | 273 | $11K | |
| 73130 | <1% | 751 | $11K | |
| 74018 | <1% | 483 | $11K | |
| 73110 | <1% | 635 | $10K | |
| 64633 | <1% | 37 | $10K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 289 | $10K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,344 | $9K |
| 64634 | <1% | 37 | $8K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 222 | $6K |
| 90473 | <1% | 237 | $4K | |
| 92557 | <1% | 191 | $4K | |
| 72040 | <1% | 210 | $4K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 111 | $3K |
| 99381 | <1% | 29 | $3K | |
| 92511 | <1% | 27 | $3K | |
| 87807 | <1% | 196 | $2K | |
| 64492 | <1% | 56 | $2K | |
| 90710 | <1% | 406 | $2K | |
| 90723 | <1% | 1,507 | $2K | |
| 95912 | <1% | 18 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 184 | $2K |
| 90461 | <1% | 2,197 | $2K | |
| 92567 | <1% | 171 | $2K | |
| 92551 | <1% | 154 | $2K | |
| 99173 | <1% | 147 | $1K | |
| 92550 | <1% | 119 | $1K | |
| 90647 | <1% | 1,357 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 183 | $1K |
| 99401 | <1% | 41 | $1K | |
| 90680 | <1% | 1,008 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 32 | $1K |
| 72070 | <1% | 59 | $964.14 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 28 | $897.30 |
| 73140 | <1% | 81 | $886.40 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 23 | $874.06 |
| 90633 | <1% | 558 | $872.85 | |
| 84703 | <1% | 126 | $868.36 | |
| 99407 | <1% | 43 | $843.54 | |
| 90687 | <1% | 887 | $816.62 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 15 | $786.24 |
| 92588 | <1% | 15 | $683.50 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 57 | $670.72 |
| 31231 | <1% | 14 | $567.19 | |
| 90651 | <1% | 41 | $535.31 | |
| 97162 | <1% | 12 | $461.23 | |
| 99406 | <1% | 45 | $414.61 | |
| 90696 | <1% | 105 | $315.80 | |
| 90734 | <1% | 66 | $306.70 | |
| 97161 | <1% | 14 | $290.50 | |
| 92504 | <1% | 29 | $276.98 | |
| 73501 | <1% | 16 | $276.28 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 67 | $227.11 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 14 | $155.48 |
| 73120 | <1% | 17 | $151.04 | |
| 73660 | <1% | 16 | $121.83 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 89 | $105.28 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 76 | $91.09 |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 20 | $68.00 |
| 99000 | <1% | 264 | $60.56 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 29 | $44.93 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 28 | $30.58 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 58 | $1.81 |
| 1159F | 0% | 5,453 | $0.00 | |
| 3078F | 0% | 4,402 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 295 | $0.00 |
| 3725F | 0% | 369 | $0.00 | |
| 1160F | 0% | 4,201 | $0.00 | |
| 3077F | 0% | 150 | $0.00 | |
| 99072 | 0% | 30 | $0.00 | |
| 99499 | 0% | 12 | $0.00 | |
| 1036F | 0% | 5,580 | $0.00 | |
| 1125F | 0% | 8,128 | $0.00 | |
| 3074F | 0% | 6,118 | $0.00 | |
| 3079F | 0% | 2,068 | $0.00 | |
| 3008F | 0% | 8,676 | $0.00 | |
| 3075F | 0% | 405 | $0.00 | |
| 1034F | 0% | 973 | $0.00 | |
| 1126F | 0% | 1,347 | $0.00 | |
| 1170F | 0% | 139 | $0.00 | |
| 90677 | 0% | 29 | $0.00 | |
| 3080F | 0% | 209 | $0.00 | |
| 3044F | 0% | 41 | $0.00 | |
| 3353F | 0% | 13 | $0.00 | |
| 1035F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARELLANO, JENNIFER (COO)
| Provider | Location | Paid |
|---|---|---|
| Catholic Charities of the Diocese of Joliet | Joliet, IL | $1.13M |
| Catholic Charities of the Diocese of Joliet | Kankakee, IL | $81K |
| Catholic Charities of the Diocese of Joliet | Downers Grove, IL | $10K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.